Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Cell Impact reports smaller quarterly loss, revenue sharply down
Cell Impact reports a loss of SEK 0.19 per share for the quarter ended 31 Dec 2025 (previous year: -0.35 SEK) on revenue of SEK 1.1m, a decline of 50.9% from SEK 2.2m. For the full year, loss per share fell to SEK 0.65 (previous year: -0.92 SEK), and annual revenue fell to SEK 5.57m, down 85.1% from SEK 37.33m in the previous year. » More on finanzen.net
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 129.13K | 32.16% |
| Gross profit | -1.56M | 2,149.44% |
| Net profit | -1.59M | 16.42% |
| EBITDA | -1M | 9.88% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €771.07K |
Number of shares | 293.49M |
52-week high/low | €0.0566 - €0.00252 |
| Dividends | No |
Beta | 1.81 |
P/E ratio | -0.07 |
PEG ratio | 0.00 |
P/B ratio | 0.16 |
P/S ratio | 1.70 |
Company profile
| Name | Cell Impact AB |
| CEO | Daniel Vallin |
| Employees | 25 |
